Key result
CCTA identifies plaque features linked to increased risk of acute coronary events.
Why the study?
Characterization of coronary atherosclerosis by CCTA provides independent and incremental prognostic value beyond traditional CAD measures and identifies patients at risk of future events.
Does coronary computed tomography angiography (CCTA) plaque characterization identify patients at increased risk of cardiovascular events?
Does coronary computed tomography angiography (CCTA) plaque characterization identify patients at increased risk of cardiovascular events?
CCTA provides independent prognostic value beyond traditional measures by characterizing high-risk coronary plaque features.
Answers are grounded in this paper and cite their sources.
CCTA plaque features may refine event risk prediction beyond stenosis; leaves open whether characterization changes management or outcomes.
PURPOSE OF REVIEW: Multicenter studies showed that the characterization of coronary atherosclerosis by coronary computed tomography (CT) angiography (CCTA) provides independent and incremental prognostic value above and beyond traditional measures of coronary artery disease (CAD) and is able to identify patients at risk of future event. Aim of the present review is to expound the major imaging plaque features associated with increased risk of coronary event and to review the data supporting the usefulness of CCTA as tool for plaque assessment and for monitoring the changes in atherosclerotic burden. RECENT FINDINGS: The evaluation of coronary atherosclerosis, including the measurement of imaging risk scores (e.g. CT-adapted Leaman score) was demonstrated as independent long-term predictor of acute coronary events. In particular, qualitative (remodelling index, low-attenuation plaque, napkin-ring sign, small spotty calcifications) and quantitative (plaque burden, total-, noncalcific- and fibrofatty plaque volume) plaque features were associated with increased risk. CCTA was also demonstrated to accurately quantify plaque volume vs. intravascular ultrasound and findings from PARADIGM and EVAPORATE studies supported the use of CCTA as noninvasive tool to follow the effect of medication on plaque progression/regression. Finally, interesting relationship between plaque features, coronary physiology and biomarkers have been described. SUMMARY: Latest guidelines on the management of patients with stable CAD recommended CCTA in Class I of evidence, particularly when 'information on atherosclerosis are desired', underlining the usefulness of CCTA to characterize and quantify the atherosclerotic burden.
No takes yet. Share an insight, caveat, or question.
Andreini et al. (2021) conducted a review in Coronary artery disease. Coronary computed tomography angiography (CCTA) was evaluated. Coronary computed tomography angiography (CCTA) provides independent prognostic value and identifies qualitative and quantitative plaque features associated with increased risk of acute coronary events.
Synapse has enriched 10 related papers. Consider them for comparative context: